Ulcer after gastric sleeve surgery is a recognised complication that can arise following sleeve gastrectomy, the UK's most commonly performed bariatric procedure. Although removing the majority of the stomach reduces acid output, the remaining sleeve mucosa — particularly along the staple line — remains vulnerable to ulceration. Understanding why these ulcers develop, how to recognise their symptoms, and what treatment options are available on the NHS is essential for anyone who has undergone this procedure. This article covers the key risk factors, warning signs, medical and lifestyle management, and when to seek urgent help.

Why Ulcers Can Develop After Gastric Sleeve Surgery

Ulcers after sleeve gastrectomy most commonly form at the staple line due to mucosal ischaemia, devascularisation during surgery, bile reflux, or risk factors such as NSAID use, H. pylori infection, and smoking.

Gastric sleeve surgery, formally known as sleeve gastrectomy, involves removing approximately 75–80% of the stomach to create a narrow, tube-shaped pouch. Whilst this procedure is highly effective for weight loss and managing obesity-related conditions, it does alter the stomach's anatomy and physiology in ways that can increase the risk of developing an ulcer — most commonly a staple-line ulcer or gastric ulcer within the sleeve itself.

Note: the term 'marginal ulcer' is more specifically associated with Roux-en-Y gastric bypass, where ulceration occurs at the gastrojejunal anastomosis, and is not the preferred term following sleeve gastrectomy.

Ulcer formation after sleeve gastrectomy is multifactorial. Recognised contributors include local mucosal ischaemia along the staple line (related to devascularisation during surgery), direct irritation of the staple line in the early post-operative period, bile reflux, and retained suture or staple material. The resection of the gastric fundus — which contains a significant proportion of acid-producing parietal cells — means that acid output may actually be reduced after sleeve gastrectomy; however, the remaining mucosa can still be vulnerable to ulceration, particularly at the staple line where tissue integrity is altered.

Several risk factors are known to increase the likelihood of developing an ulcer after gastric sleeve surgery:

• Non-steroidal anti-inflammatory drug (NSAID) use — medications such as ibuprofen and naproxen are strongly associated with ulcer formation and should generally be avoided post-operatively; aspirin should only be continued if specifically prescribed for a cardiovascular indication, under medical supervision

• Helicobacter pylori (H. pylori) infection — this bacterium damages the stomach lining and is a well-established cause of peptic ulcers; many UK bariatric programmes screen for and treat H. pylori before surgery to reduce post-operative ulcer risk, in line with BOMSS guidance

• Smoking — impairs mucosal blood flow, reduces protective prostaglandin synthesis, and delays healing

• Alcohol consumption — irritates the gastric lining directly

• Physiological stress in the post-surgical period — though the evidence linking psychological stress directly to ulcer formation is limited, it may influence symptom perception and recovery

It is worth noting that whilst ulcers after gastric sleeve surgery are a recognised complication, they are not inevitable. With appropriate precautions, preoperative screening, and follow-up care, the risk can be meaningfully reduced.

Recognising the Symptoms of a Post-Sleeve Ulcer

The most common symptom is epigastric burning or gnawing pain; other warning signs include nausea, vomiting blood, melaena, dysphagia, and unexplained fatigue suggesting anaemia.

Identifying an ulcer after gastric sleeve surgery can sometimes be more challenging than recognising a conventional peptic ulcer, partly because the altered anatomy changes how symptoms present. However, there are several characteristic signs that patients and clinicians should be aware of.

The most commonly reported symptom is epigastric pain — a burning, gnawing, or aching discomfort felt in the upper central abdomen. In post-sleeve patients, this pain may be felt more acutely given the reduced stomach volume. The pain may worsen after eating or, conversely, improve temporarily with food or antacids, depending on the ulcer's location and severity.

Other symptoms to be aware of include:

• Nausea and vomiting — particularly if vomiting contains blood or material resembling coffee grounds, which may indicate bleeding

• Dysphagia or odynophagia (difficulty or pain on swallowing) — these are important symptoms requiring prompt assessment

• Heartburn or acid reflux — whilst some degree of reflux can occur after sleeve gastrectomy, a worsening or new onset of symptoms warrants investigation

• Loss of appetite or early satiety — beyond what is expected post-operatively

• Unexplained weight loss — distinct from the intended surgical weight loss

• Dark or tarry stools (melaena) — a potential sign of upper gastrointestinal bleeding requiring urgent attention

• Fatigue or pallor — which may suggest anaemia secondary to chronic blood loss; clinicians may check a full blood count (FBC) and ferritin if this is suspected

It is important to recognise that some patients may experience a so-called silent ulcer, presenting with minimal or no pain, particularly those taking NSAIDs, which can mask discomfort. Any persistent or unusual gastrointestinal symptoms following gastric sleeve surgery should be reported to a GP or bariatric team promptly, rather than attributed solely to the expected post-operative adjustment period. For guidance on alarm features that should prompt urgent referral, see the section below on when to seek urgent medical advice.

Treatment Options Available on the NHS

Upper GI endoscopy confirms the diagnosis, and PPI therapy is the primary treatment; H. pylori eradication and endoscopic haemostasis are used where indicated, guided by NICE and BSG guidelines.

If an ulcer is suspected following gastric sleeve surgery, the first step is typically a referral for upper gastrointestinal endoscopy (gastroscopy), which allows direct visualisation of the stomach lining and staple line. This investigation is considered the gold standard for diagnosing post-operative ulcers and can also facilitate biopsy to test for H. pylori infection or rule out other pathology, including malignancy. NICE CG184 (Gastro-oesophageal reflux disease and dyspepsia in adults) supports prompt endoscopic investigation in patients presenting with alarm features such as dysphagia, unexplained weight loss, or persistent vomiting. Where there is concern about possible upper gastrointestinal cancer, clinicians should also refer to NICE NG12 (Suspected cancer: recognition and referral) for urgent two-week-wait referral criteria.

The cornerstone of medical treatment for ulcers after gastric sleeve surgery is proton pump inhibitor (PPI) therapy. Medications such as omeprazole or lansoprazole work by inhibiting the hydrogen-potassium ATPase enzyme in gastric parietal cells, thereby significantly reducing acid secretion. Dosing and duration should follow BNF recommendations and individual product SmPCs. In post-bariatric patients, PPIs are often prescribed at standard or higher doses for a minimum of 8–12 weeks; many UK bariatric programmes, in line with BOMSS postoperative medication guidance, prescribe PPIs prophylactically for approximately six months following sleeve gastrectomy. Long-term or indefinite PPI use should only continue where clearly clinically indicated, with regular review and step-down to the lowest effective dose when appropriate, given the recognised risks of prolonged PPI therapy (including hypomagnesaemia and increased infection susceptibility). Patients or carers who suspect a side effect from a PPI or any other medicine should report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Where H. pylori infection is confirmed, management should follow the NICE guideline on Helicobacter pylori: antimicrobial prescribing. In UK primary care, this typically consists of a seven-day course of triple therapy: a PPI combined with two antibiotics (commonly amoxicillin and clarithromycin, or metronidazole if penicillin-allergic). Local antimicrobial resistance patterns should be considered, particularly where prior macrolide exposure is documented. A follow-up breath test or stool antigen test is usually performed at least four weeks after completing antibiotics, with a two-week PPI washout before testing to avoid false-negative results, in order to confirm eradication.

In cases where ulcers fail to heal with medical management, or where complications such as significant bleeding arise, urgent hospital assessment is required. Bleeding ulcers are managed according to the BSG guideline on acute upper gastrointestinal bleeding, which includes risk stratification, resuscitation, and endoscopic haemostasis (such as adrenaline injection, thermal coagulation, or haemostatic clips) where appropriate. Surgical intervention is relatively uncommon but remains an important option within NHS bariatric care pathways for refractory or perforated ulcers. Patients should remain under the follow-up of their bariatric multidisciplinary team throughout treatment.

Lifestyle and Dietary Changes to Support Recovery

Avoiding NSAIDs and alcohol, stopping smoking, eating small frequent meals, and staying hydrated help reduce gastric irritation and support recovery alongside medical treatment.

Alongside medical treatment, lifestyle and dietary modifications play an important role in reducing symptom burden and supporting recovery after gastric sleeve surgery. Given the already restricted stomach capacity, dietary choices have a particularly significant impact on gastric comfort in this patient group. It should be noted that the dietary measures below are primarily aimed at reducing reflux and gastric irritation rather than being proven to accelerate ulcer healing directly.

Dietary adjustments that may help manage symptoms include:

• Eating small, frequent meals rather than larger portions to avoid overloading the sleeve and minimising acid exposure

• Avoiding foods and drinks that commonly worsen reflux or gastric discomfort, including spicy foods, citrus fruits, tomato-based products, carbonated drinks, and caffeine — though individual tolerance varies

• Chewing food thoroughly and eating slowly to reduce mechanical stress on the stomach

• Staying well hydrated with still water, sipping fluids between rather than during meals

• Avoiding alcohol entirely during the healing period, as it directly damages the gastric mucosa

Smoking cessation is strongly advised for all post-bariatric patients with an ulcer. Smoking impairs mucosal blood flow, reduces prostaglandin synthesis (which is protective to the stomach lining), and delays healing. NHS Stop Smoking Services offer free, evidence-based support and can be accessed via a GP referral or self-referral.

Patients should also be counselled to avoid NSAIDs such as ibuprofen and naproxen, as these inhibit cyclooxygenase enzymes and reduce the production of protective prostaglandins in the gastric lining. Paracetamol is generally considered a safer alternative for pain relief in this context. Importantly, patients who have been prescribed low-dose aspirin or antiplatelet therapy for a cardiovascular indication should not stop this medication without first seeking medical advice; where continued NSAID or antiplatelet use is necessary, co-prescription of a PPI for gastroprotection should be considered in discussion with the prescribing clinician.

Managing psychological wellbeing through techniques such as mindfulness, cognitive behavioural therapy (CBT), or structured relaxation may support coping and overall recovery, though the direct evidence for stress reduction improving ulcer healing is limited. Bariatric psychology services, where available, can provide valuable support during this period.

When to Seek Urgent Medical Advice

Call 999 or go to A&E immediately if you vomit blood, pass black tarry stools, or develop sudden severe abdominal pain, as these indicate potentially life-threatening complications such as bleeding or perforation.

Whilst many post-sleeve ulcers can be managed effectively with medication and lifestyle changes, certain symptoms indicate a potentially serious complication requiring prompt or emergency medical attention. Patients and their carers should be clearly informed of these warning signs as part of their post-operative education.

Contact your GP or bariatric team promptly, or call NHS 111 for urgent advice, if you experience:

• Persistent or worsening upper abdominal pain that is not relieved by prescribed medication

• Nausea or vomiting that prevents you from keeping fluids or medications down

• New or worsening heartburn or reflux symptoms

• Difficulty swallowing (dysphagia) or pain on swallowing (odynophagia)

• Unexplained fatigue, dizziness, or shortness of breath, which may suggest anaemia from slow bleeding

Call 999 or go to your nearest A&E immediately if you notice:

• Vomiting blood or material that resembles coffee grounds — this is a sign of active upper gastrointestinal bleeding

• Black, tarry, or very dark stools (melaena) — indicating digested blood in the gastrointestinal tract

• Sudden, severe abdominal pain — which may indicate ulcer perforation, a surgical emergency

• Signs of shock, including rapid heart rate, pale or clammy skin, confusion, or collapse

It is also important for patients to attend all scheduled follow-up appointments with their bariatric team, even if they feel well. Endoscopic follow-up after a diagnosed ulcer is guided by clinical judgement and specialist recommendation — for example, where an ulcer has been slow to heal or where risk factors persist — rather than being a routine requirement for all post-sleeve patients. Decisions about further endoscopy should be made in discussion with the bariatric multidisciplinary team.

Open communication with the multidisciplinary team — including the bariatric surgeon, dietitian, and GP — is essential for safe, long-term recovery. Any symptom that deviates from the expected recovery trajectory should be investigated rather than dismissed. Early intervention consistently leads to better outcomes and reduces the risk of serious complications.

Frequently Asked Questions